Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given an average rating of “Buy” by the twenty research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $354.60.

Several research analysts have commented on ISRG shares. Wedbush reaffirmed an “outperform” rating and set a $353.33 price target on shares of Intuitive Surgical in a research report on Monday, September 25th. Barclays reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target on the stock in a research report on Tuesday, December 12th. Finally, Goldman Sachs Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th.

Intuitive Surgical (ISRG) traded up $5.74 on Tuesday, reaching $397.60. The company’s stock had a trading volume of 1,372,640 shares, compared to its average volume of 929,940. The firm has a market capitalization of $44,550.00, a price-to-earnings ratio of 51.37, a price-to-earnings-growth ratio of 5.33 and a beta of 0.47. Intuitive Surgical has a 52 week low of $213.91 and a 52 week high of $405.05.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, topping the consensus estimate of $1.99 by $0.78. The company had revenue of $806.10 million for the quarter, compared to analyst estimates of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The firm’s revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.06 earnings per share. research analysts expect that Intuitive Surgical will post 7.85 EPS for the current year.

In related news, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $400.00, for a total transaction of $1,200,000.00. Following the transaction, the senior vice president now owns 9,888 shares of the company’s stock, valued at $3,955,200. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Salvatore Brogna sold 6,082 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $397.61, for a total value of $2,418,264.02. Following the transaction, the chief operating officer now directly owns 3,096 shares in the company, valued at approximately $1,231,000.56. The disclosure for this sale can be found here. In the last three months, insiders sold 55,944 shares of company stock worth $21,432,971. Corporate insiders own 2.20% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the stock. ETF Managers Group LLC purchased a new stake in Intuitive Surgical during the second quarter worth $110,000. Harvest Fund Management Co. Ltd purchased a new stake in Intuitive Surgical during the second quarter worth $120,000. Parallel Advisors LLC boosted its position in Intuitive Surgical by 195.6% during the third quarter. Parallel Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $184,000 after purchasing an additional 311 shares in the last quarter. Lincoln National Corp purchased a new stake in Intuitive Surgical during the third quarter worth $200,000. Finally, MUFG Americas Holdings Corp purchased a new stake in Intuitive Surgical during the third quarter worth $208,000. 32.80% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Intuitive Surgical, Inc. (ISRG) Given Consensus Recommendation of “Buy” by Brokerages” was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/intuitive-surgical-inc-isrg-given-consensus-recommendation-of-buy-by-brokerages/1800213.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with Analyst Ratings Network's FREE daily email newsletter.